In brief
South Africa’s baby‑food sector is entering a more exposed regulatory phase as strict infant‑food marketing rules intersect with heightened product‑safety enforcement. Although the regulatory framework governing infant nutrition has long been robust, recent recalls involving contamination risks, misclassified paediatric supplements and cross‑border supply‑chain failures highlight growing legal, operational and reputational vulnerability. Regulators are taking an increasingly assertive approach, while the Consumer Protection Act’s strict‑liability regime continues to attach responsibility to suppliers regardless of fault. For manufacturers, importers and distributors, compliance now extends beyond labels and advertising into governance, traceability and recall preparedness. Organisations that treat compliance as a strategic priority rather than a procedural obligation will be better positioned to maintain trust in a highly sensitive market.
In more detail
South Africa’s baby‑food industry is experiencing a period of unprecedented regulatory tension. While the legislative framework governing infant‑food marketing remains among the most stringent globally, recent waves of product recalls have exposed new vulnerabilities, reverberating across supply chains, corporate‑governance structures, and consumer‑protection obligations. For businesses operating in this sector, and for their legal advisors, these developments underscore an emerging reality: compliance is no longer a paperwork exercise; it is a foundational strategic imperative.
South Africa’s Regulations Relating to Foodstuffs for Infants and Young Children, issued under the Foodstuffs, Cosmetics and Disinfectants Act 54 of 1972, impose strict controls on how infant‑feeding products may be manufactured, marketed, labelled, and sold. These Regulations classify a range of “designated product” and set detailed rules on composition, labelling, and advertising, expressly prohibiting marketing practices that could mislead caregivers or undermine breastfeeding.
Importantly, the Regulations are aligned with the WHO’s International Code of Marketing of Breast‑Milk Substitutes, a global policy framework that restricts advertising, free samples, promotional gifts, and other forms of commercial influence to prioritise breastfeeding and protect vulnerable decision‑makers.
Marketing Restrictions: The Compliance “Red Zone”
The advertising restrictions in the Regulations are intentionally uncompromising. The law prohibits any form of direct-to-consumer advertising for infant formula, follow-up formula, and other designated infant-feeding products, including the use of imagery or messaging that may idealise formula feeding. This extends to a strict ban on promotional discounts, special offers, giveaways, free samples, and point-of-sale inducements, reflecting evidence that such activities undermine breastfeeding and distort caregiver decision-making.
The Regulations also place significant constraints on engagement with healthcare professionals. Manufacturers may share only factual, scientific information, consistent with the WHO Code’s prohibitions on promotional materials, gifts, or inducements. Product samples may be provided only for institutional research, never to mothers. Although stringent, these rules do not transform infant-feeding products into scheduled medicines; rather, they recognise that infant nutrition products require a uniquely high level of marketing control due to their public-health implications.
With such tight prohibitions, businesses face heightened compliance risk, ranging from marketing teams inadvertently overstepping regulatory boundaries to retailers unintentionally including restricted products in promotional activity.
A Parallel Risk Landscape: The Surge in Baby-Food Recalls
In recent months, attention has shifted from marketing compliance to product-safety risks, with several recalls between January and March 2026 demonstrating how quickly safety lapses can escalate into regulatory intervention.
Listeria contamination:
In March 2026, the National Consumer Commission, the regulator responsible for enforcing consumer-protection laws, recalled a toddler snack product after detecting Listeria in more than 1,100 units. Although the strain was considered non-pathogenic, the recall reflected a precautionary approach given infants’ vulnerability and echoed South Africa’s broader history of Listeria-related public-health challenges.
Cereulide contamination in infant formula:
The NCC also recalled nearly 3,000 units of infant‑formula products following the identification of a potential contamination risk involving cereulide, a heat‑stable toxin known to cause gastrointestinal distress. This recall formed part of a broader global safety alert, as international regulators identified the same toxin risk in batches manufactured abroad and distributed across multiple markets. In South Africa, the affected products had been available nationwide since August 2025, prompting urgent withdrawal notices.
Cross-border supply-chain risk:
A further recall arose from the same cereulide contamination issue, this time involving formula manufactured at an overseas facility and exported into South Africa and neighbouring countries. This demonstrated how globalised supply chains can magnify the impact of upstream failures. A single contaminated ingredient source can trigger simultaneous recalls across continents, long after products have moved through distributors and retailers. For South African market participants, this creates heightened exposure under the Consumer Protection Act 68 of 2008, whose strict‑liability regime holds suppliers responsible for unsafe products regardless of whether the defect originated within South Africa or in a foreign jurisdiction.
Unsafe paediatric supplements:
The South African Health Products Regulatory Authority, responsible for ensuring the safety, quality, and compliance of medicines and health products, ordered the withdrawal of children’s supplements containing zinc picolinate and selenium after identifying safety risks and unlawful marketing practices. These ingredients are not permitted in paediatric supplements under SAHPRA’s guidance due to unpredictable side‑effects and overdose risks. Because the products were marketed as paediatric “immune boosters,” implying treatment of various illnesses, they met the definition of medicines, not complementary supplements. Their sale without registration was therefore illegal, prompting SAHPRA to mandate full market withdrawal within six months.
The incident underscores regulatory expectations around accurate product classification and the need for rigorous safety assessments especially for products intended for children.
Taken together, these developments reveal a sector under sustained pressure where even isolated quality-control failures can trigger cascading legal, reputational, and operational consequences. At the same time, they highlight the increasingly complex regulatory environment in which infant-nutrition businesses must operate.
Regulators are adopting a more assertive posture, supply-chain scrutiny is intensifying, and the Consumer Protection Act 68 of 2008 continues to impose strict liability regardless of intent. At the same time, expectations around responsible governance and sustainable business practices are rising, placing product safety and ethical marketing firmly at the centre of corporate governance and stakeholder-trust agendas.
The convergence of strict marketing rules and heightened product‑safety vigilance signals a decisive shift in the infant‑nutrition landscape. Yet within this tightening regulatory environment lies a clear opportunity. Companies that approach compliance not as a burden but as a strategic asset will be best positioned to build trust, strengthen resilience, and differentiate themselves in a sensitive and highly regulated market.
For industry and counsel alike, the path forward is to invest in proactive compliance, deepen supply‑chain oversight, enhance recall readiness, and engage constructively with regulators. In a market defined by its responsibility to infants and young children, credibility is earned through vigilance and preserved through compliance.